Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

Peer Review reports

Original Submission
23 Feb 2012	Submitted	Original manuscript
27 Apr 2012	Reviewed	Reviewer Report - Werner C. Albrich
2 May 2012	Reviewed	Reviewer Report - Andrew Christopher Whitelaw
12 Jun 2012	Author responded	Author comments - Anna Marchese
Resubmission - Version 2
12 Jun 2012	Submitted	Manuscript version 2
16 Jul 2012	Reviewed	Reviewer Report - Andrew Christopher Whitelaw
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
27 Jul 2012	Editorially accepted
6 Aug 2012	Article published	10.1186/1471-2334-12-181

Back to article page